Fortunately, you can tweak your diet to handle your nausea and get the nutrients you need. Here's what to eat and what to ...
Despite highly effective HIV prevention drugs on the market, only a fraction of those at risk in the U.S. are taking them — or even know they're an option. It's called pre-exposure prophylaxis, or ...
A randomized clinical trial led by Johns Hopkins researchers finds that giving patients a next-day HIV viral load (VL) test ...
After abruptly pausing PEPFAR on Tuesday — the U.S.-led HIV/AIDS program created in 2003 and credited with saving 25 million lives globally — the Trump administration issued an ambiguous waiver for ...
WHO’s 2025 HIV clinical guidelines simplify and strengthen care by recommending more durable, safer treatment regimens, ...
Zacks Investment Research on MSN
Will GILD's strong HIV portfolio reap rewards in 2026?
Gilead Sciences, Inc. GILD has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy and Descovy. Biktarvy ...
HOUSTON — With President Trump's "Big, Beautiful Bil l," making major cuts to Medicaid, health care professionals and patients are warning of the potentially deadly consequences for people living with ...
A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
Kaiser Permanente has stopped charging people more for HIV drugs and is offering refunds for the exorbitant copays some of its patients faced. The decision comes as two state lawmakers have introduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results